INTRODUCTION: To evaluate the protective effect and the optimum duration of cerebrospinal fluid drainage (CSFD) during and after thoracoabdominal aortic aneurysm (TAAA) repair. METHODS: From April 2001 to October 2003, we retrospectively compared 17 (n = 17) consecutive patients who have been electively operated on by Martin Grabenwoger for left heart bypass and selective perfusion of the visceral and renal organs. RESULTS: The first 7 patients had CSFD for 72 hours; the duration of CSFD was increased to 100 hours in the remaining 10 patients. Median drained cerebrospinal fluid (CSF) volume was 680 milliliters in the 72-hour group versus 1441 milliliters in the 100-hour group. A characteristic increase in CSF volume was noted between POD No. 2 and POD No. 4 indicating persistent spinal cord edema. Univariate and multivariate analysis demonstrated that CSFD for 100 hours is a significant predictor for decreased incidence of late onset paraplegia (p < 0.001). The overall incidence of postoperative neurological deficit was 17.6% (3 of 17). There was one patient (6%) who developed permanent paraplegia and two patients (12%) with transient paraplegia. These patients sustained late-onset paraplegia 72 hours after surgery for removal of a CSFD device. Complete motor function could be restored after re-insertion of a CSFD device. In one patient, permanent paraplegia was evident after awakening from anesthesia. Because of technical difficulties, only two intercostal arteries could be re-implanted, which was obviously not sufficient to restore spinal cord perfusion. In contrast, no neurological deficit occurred in patients in whom a CSFD instrument was left for 100 hours. CONCLUSION: The extended duration of CSFD may lower the risk of late-onset paraplegia and could improve outcome in patients undergoing thoracoabdominal aortic surgery.
INTRODUCTION: To evaluate the protective effect and the optimum duration of cerebrospinal fluid drainage (CSFD) during and after thoracoabdominal aortic aneurysm (TAAA) repair. METHODS: From April 2001 to October 2003, we retrospectively compared 17 (n = 17) consecutive patients who have been electively operated on by Martin Grabenwoger for left heart bypass and selective perfusion of the visceral and renal organs. RESULTS: The first 7 patients had CSFD for 72 hours; the duration of CSFD was increased to 100 hours in the remaining 10 patients. Median drained cerebrospinal fluid (CSF) volume was 680 milliliters in the 72-hour group versus 1441 milliliters in the 100-hour group. A characteristic increase in CSF volume was noted between POD No. 2 and POD No. 4 indicating persistent spinal cord edema. Univariate and multivariate analysis demonstrated that CSFD for 100 hours is a significant predictor for decreased incidence of late onset paraplegia (p < 0.001). The overall incidence of postoperative neurological deficit was 17.6% (3 of 17). There was one patient (6%) who developed permanent paraplegia and two patients (12%) with transient paraplegia. These patients sustained late-onset paraplegia 72 hours after surgery for removal of a CSFD device. Complete motor function could be restored after re-insertion of a CSFD device. In one patient, permanent paraplegia was evident after awakening from anesthesia. Because of technical difficulties, only two intercostal arteries could be re-implanted, which was obviously not sufficient to restore spinal cord perfusion. In contrast, no neurological deficit occurred in patients in whom a CSFD instrument was left for 100 hours. CONCLUSION: The extended duration of CSFD may lower the risk of late-onset paraplegia and could improve outcome in patients undergoing thoracoabdominal aortic surgery.
Authors: Joseph S Coselli; Scott A LeMaire; Lon D Conklin; Cüneyt Köksoy; Zachary C Schmittling Journal: Ann Thorac Surg Date: 2002-04 Impact factor: 4.330
Authors: John E Rectenwald; Thomas S Huber; Tomas D Martin; C Keith Ozaki; Meenakshi Devidas; M Burress Welborn; James M Seeger Journal: J Vasc Surg Date: 2002-04 Impact factor: 4.268
Authors: Albert T Cheung; Stuart J Weiss; Michael L McGarvey; Mark M Stecker; Michael S Hogan; Alison Escherich; Joseph E Bavaria Journal: Ann Thorac Surg Date: 2002-08 Impact factor: 4.330
Authors: H J Safi; S Bartoli; K R Hess; S S Shenaq; J R Viets; G R Butt; R Sheinbaum; H K Doerr; R Maulsby; V M Rivera Journal: J Vasc Surg Date: 1994-09 Impact factor: 4.268
Authors: E S Crawford; L G Svensson; K R Hess; S S Shenaq; J S Coselli; H J Safi; P K Mohindra; V Rivera Journal: J Vasc Surg Date: 1991-01 Impact factor: 4.268
Authors: H J Safi; K R Hess; M Randel; D C Iliopoulos; J C Baldwin; R K Mootha; S S Shenaq; R Sheinbaum; T Greene Journal: J Vasc Surg Date: 1996-02 Impact factor: 4.268
Authors: Michael L McGarvey; Michael T Mullen; Edward Y Woo; Joseph E Bavaria; Yanni G Augoustides; Steven R Messé; Albert T Cheung Journal: Neurocrit Care Date: 2007 Impact factor: 3.210